Prevalence of gait disorders in hospitalized neurological patients

Movement Disorders : Official Journal of the Movement Disorder Society
Henning StolzeGünther Deuschl

Abstract

The prevalence of gait disorders among neurological inpatients is unknown, although disturbed gait is a common symptom. Gait disorders often lead to loss of independence with restraints for the patients and caregivers and costs for the health system. We designed a prospective study and investigated all patients admitted to a neurological hospital during a 100-day period for the presence of a gait disorder. Clinical investigation and several disease-specific rating scales were carried out for 493 patients. In 60% of the patients, a disturbance of gait was diagnosed. Most frequent diagnoses were stroke (21%), Parkinson's disease (17%), and polyneuropathy (7%). Within these diagnoses, the rate of patients with disturbed gait was high in Parkinson's disease (93%), subcortical arteriosclerotic encephalopathy (85%), and motor neuron disease (83%). Advanced age, dementia, alcohol abuse, and treatment with antiepileptics, neuroleptics, benzodiazepines, and chemotherapeutics were identified as risk factors for a gait disorder. A decline of cognitive function was accompanied by a reduction of walking speed. According to these results, gait disorders are among the most frequent symptoms in neurology.

Associated Clinical Trials

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Feb 1, 1992·Journal of Neurology·R J ElbleC Higgins
Jun 1, 1987·Seminars in Neurology·S Fahn
Sep 1, 1994·Journal of Clinical Epidemiology·W A KukullM L Pfanschmidt
Jul 1, 1996·Age and Ageing·S T O'KeeffeM Lye
Mar 5, 2004·Journal of Neurology·Henning StolzeGünther Deuschl

❮ Previous
Next ❯

Citations

Jan 31, 2008·Der Nervenarzt·H StolzeG Deuschl
Jul 23, 2008·Journal of Neurologic Physical Therapy : JNPT·Eric D VidoniPatricia Kluding
Jan 19, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·A NieuwboerI Lim
Jan 26, 2013·Annals of Indian Academy of Neurology·Mohamed S El-TamawyMohamed E Khallaf
Mar 28, 2013·Parkinson's Disease·Natalie E AllenColleen G Canning
Feb 8, 2014·Neurophysiologie clinique = Clinical neurophysiology·A DelvalL Defebvre
May 29, 2014·Der Nervenarzt·K AmadoriT Steiner
May 30, 2014·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Nicole L PrattElizabeth E Roughead
Feb 13, 2009·Physiotherapy Theory and Practice·Birgitta LanghammerBirgitta Lindmark
Jul 21, 2009·Revue neurologique·A GuillochonF Puisieux
Jun 1, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·John G NuttBastiaan R Bloem
Jan 15, 2015·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Marie Anne GebaraEric J Lenze
Sep 17, 2014·Journal of Neurology, Neurosurgery, and Psychiatry·Gennaro PaganoMichele Tagliati
May 19, 2010·Biomarkers in Medicine·Andrew TarnarisLaurence D Watkins
Oct 3, 2006·Expert Review of Neurotherapeutics·John C Morgan, Kapil D Sethi
May 6, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Jack J Chen, Anh-Vuong Ly
May 14, 2019·Multiple Sclerosis : Clinical and Laboratory Research·Christian MeyerLinard Filli
Sep 29, 2017·Neurology·Inbal MaidanAnat Mirelman
Oct 5, 2013·Continuum : Lifelong Learning in Neurology·Alfonso Fasano, Bastiaan R Bloem
Jul 30, 2010·Disability and Rehabilitation. Assistive Technology·Ksenia UstinovaNancy Epstein
Jan 1, 2014·International Scholarly Research Notices·Lorenza PrataliAngelo Gemignani
Nov 10, 2017·Annals of Biomedical Engineering·Carlos TobarSeung-Jae Kim
Sep 13, 2018·Zeitschrift für Gerontologie und Geriatrie·Markus A HobertMichael Jamour
Aug 12, 2020·Journal of Neuroengineering and Rehabilitation·M BannwartC A Easthope
Mar 28, 2019·Scientific Reports·Christian MeyerLinard Filli
May 11, 2019·Journal of Neuroengineering and Rehabilitation·Maria Del Carmen Sanchez-VillamañanJose L Pons
Sep 15, 2020·Journal of Parkinson's Disease·Jaimie A RoperUNKNOWN Parkinson’s Foundation Quality Improvement Initiative Investigators
Dec 25, 2019·Journal of Neuroengineering and Rehabilitation·M BannwartM Bolliger
Dec 1, 2020·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Douglas N MartiniFay B Horak
May 22, 2010·Deutsches Ärzteblatt International·Klaus JahnRoman Schniepp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here